
Alphatec Hlds (ATEC) Stock Forecast & Price Target
Alphatec Hlds (ATEC) Analyst Ratings
Bulls say
Alphatec Holdings Inc has demonstrated a positive financial trajectory, highlighted by a 28% year-over-year growth in surgical revenue, amounting to $157 million, and a significant 19% increase in procedure volumes in the fourth quarter of 2024. The company's adjusted operating margin improved to 2.6%, representing a notable increase of 1,000 basis points year-over-year, which significantly outperformed market expectations. Looking ahead, Alphatec is projecting total revenues of approximately $732 million for 2025, indicating around a 20% increase over preliminary 2024 revenues, supported by a forecast of mid-single digit procedural revenue growth and mid-teens percentage growth in volumes.
Bears say
Alphatec Holdings, Inc. has demonstrated a stagnant adjusted gross margin of 69.7%, which fell short of consensus expectations, indicating challenges in revenue efficiency. The company's EBITDA guidance of $75 million suggests a concerning 37% drop in incremental revenue growth, alongside a reliance on achieving positive free cash flow by 2025, which remains uncertain. Furthermore, various risks, including poor sales execution, heightened competition, and the potential for dilutive equity offerings or acquisitions, contribute to a bearish outlook on the company's financial stability and growth prospects.
This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.
Alphatec Hlds (ATEC) Analyst Forecast & Price Prediction
Start investing in Alphatec Hlds (ATEC)
Order type
Buy in
Order amount
Est. shares
0 shares